secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-05-14T21:06:16+00:00
Accession:  0001171843-26-003441
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical to present TULSA Procedure data at AUA2026 and explore PSMA PET integration
--------------------------------------------------------------------------------

- Four oral presentations on TULSA Procedure at AUA Annual Meeting in Washington, DC on May 16, 2026.
- Presenters include Mayo Clinic's Dr. Pathak, Dr. Anttinen (Finland), and Dr. Miura (Japan) covering registry, phase 2 trial, and real-world data.
- Launches initiative to explore integration of PSMA PET molecular imaging with TULSA-PRO software for treatment planning and monitoring.
- Hosts demonstrations of TULSA-PRO and Siemens MAGNETOM Free.Max MR at booth #413 at AUA2026.
- Note: 0.55T MRI compatibility (Free.Max) not yet commercially available in all markets, including the U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326003441/0001171843-26-003441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326003441/f8k_051426.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer